AdvantiGen Biosciences specializes in the development of protein-based tools and services for research, biotechnology, and pharmaceutical industries. The company focuses on creating innovative solutions to advance medical device development and drug discovery, aiming to improve human health. AdvantiGen Biosciences offers expertise in eukaryotic and prokaryotic protein expression, protein purification, and quantification. The company holds proprietary technologies, including patented novel infrared fluorophores and processes for antibody and monobody development. AdvantiGen Biosciences collaborates with partners to develop antibodies for reagent, diagnostic, and therapeutic applications, leveraging its patented reactivation technology.